bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2023,
Volume and Issue:
unknown
Published: Sept. 28, 2023
ABSTRACT
Antigenic
drift
of
SARS-CoV-2
is
typically
defined
by
mutations
in
the
N-terminal
domain
and
receptor
binding
spike
protein.
In
contrast,
whether
antigenic
occurs
S2
remains
largely
elusive.
Here,
we
perform
a
deep
mutational
scanning
experiment
to
identify
that
affect
three
apex
public
antibodies.
Our
results
indicate
spatially
diverse
mutations,
including
D950N
Q954H,
which
are
observed
Delta
Omicron
variants,
respectively,
weaken
these
Although
antibodies
known
be
non-neutralizing,
show
they
confer
partial
protection
vivo
.
We
further
demonstrate
such
activity
diminished
natural
mutation
D950N.
Overall,
this
study
indicates
can
undergo
drift,
represents
potential
challenge
for
development
more
universal
coronavirus
vaccines.
Cell,
Journal Year:
2023,
Volume and Issue:
186(6), P. 1263 - 1278.e20
Published: Feb. 13, 2023
A
major
challenge
in
understanding
SARS-CoV-2
evolution
is
interpreting
the
antigenic
and
functional
effects
of
emerging
mutations
viral
spike
protein.
Here,
we
describe
a
deep
mutational
scanning
platform
based
on
non-replicative
pseudotyped
lentiviruses
that
directly
quantifies
how
large
numbers
impact
antibody
neutralization
pseudovirus
infection.
We
apply
this
to
produce
libraries
Omicron
BA.1
Delta
spikes.
These
each
contain
∼7,000
distinct
amino
acid
context
up
∼135,000
unique
mutation
combinations.
use
these
map
escape
from
neutralizing
antibodies
targeting
receptor-binding
domain,
N-terminal
S2
subunit
spike.
Overall,
work
establishes
high-throughput
safe
approach
measure
∼10
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2023,
Volume and Issue:
unknown
Published: Dec. 8, 2023
Predicting
the
effects
of
mutations
in
proteins
is
critical
to
many
applications,
from
understanding
genetic
disease
designing
novel
that
can
address
our
most
pressing
challenges
climate,
agriculture
and
healthcare.
Despite
a
surge
machine
learning-based
protein
models
tackle
these
questions,
an
assessment
their
respective
benefits
challenging
due
use
distinct,
often
contrived,
experimental
datasets,
variable
performance
across
different
families.
Addressing
requires
scale.
To
end
we
introduce
ProteinGym,
large-scale
holistic
set
benchmarks
specifically
designed
for
fitness
prediction
design.
It
encompasses
both
broad
collection
over
250
standardized
deep
mutational
scanning
assays,
spanning
millions
mutated
sequences,
as
well
curated
clinical
datasets
providing
high-quality
expert
annotations
about
mutation
effects.
We
devise
robust
evaluation
framework
combines
metrics
design,
factors
known
limitations
underlying
methods,
covers
zero-shot
supervised
settings.
report
diverse
70
high-performing
various
subfields
(eg.,
alignment-based,
inverse
folding)
into
unified
benchmark
suite.
open
source
corresponding
codebase,
MSAs,
structures,
model
predictions
develop
user-friendly
website
facilitates
data
access
analysis.
Protein & Cell,
Journal Year:
2024,
Volume and Issue:
15(6), P. 403 - 418
Published: March 4, 2024
Intensive
selection
pressure
constrains
the
evolutionary
trajectory
of
SARS-CoV-2
genomes
and
results
in
various
novel
variants
with
distinct
mutation
profiles.
Point
mutations,
particularly
those
within
receptor
binding
domain
(RBD)
spike
(S)
protein,
lead
to
functional
alteration
both
engagement
monoclonal
antibody
(mAb)
recognition.
Here,
we
review
data
RBD
point
mutations
possessed
by
major
discuss
their
individual
effects
on
ACE2
affinity
immune
evasion.
Many
single
amino
acid
substitutions
epitopes
crucial
for
evasion
capacity
may
conversely
weaken
affinity.
However,
this
weakened
effect
could
be
largely
compensated
specific
epistatic
such
as
N501Y,
thus
maintaining
overall
protein
all
variants.
The
predominant
direction
evolution
lies
neither
promoting
nor
evading
mAb
neutralization
but
a
delicate
balance
between
these
two
dimensions.
Together,
interprets
how
efficiently
resist
meanwhile
is
maintained,
emphasizing
significance
comprehensive
assessment
mutations.
Nature Communications,
Journal Year:
2023,
Volume and Issue:
14(1)
Published: April 10, 2023
Designing
prefusion-stabilized
SARS-CoV-2
spike
is
critical
for
the
effectiveness
of
COVID-19
vaccines.
All
vaccines
in
US
encode
with
K986P/V987P
mutations
to
stabilize
its
prefusion
conformation.
However,
contemporary
methods
on
engineering
immunogens
involve
tedious
experimental
work
and
heavily
rely
structural
information.
Here,
we
establish
a
systematic
unbiased
method
identifying
that
concomitantly
improve
expression
conformation
spike.
Our
integrates
fluorescence-based
fusion
assay,
mammalian
cell
display
technology,
deep
mutational
scanning.
As
proof-of-concept,
apply
this
region
S2
domain
includes
first
heptad
repeat
central
helix.
results
reveal
besides
K986P
V987P,
several
simultaneously
significantly
lower
fusogenicity
stabilization
common
challenge
viral
immunogen
design,
will
help
accelerate
vaccine
development
against
different
viruses.
The Journal of Immunology,
Journal Year:
2024,
Volume and Issue:
212(2), P. 235 - 243
Published: Jan. 2, 2024
Abstract
Abs
are
versatile
molecules
with
the
potential
to
achieve
exceptional
binding
target
Ags,
while
also
possessing
biophysical
properties
suitable
for
therapeutic
drug
development.
Protein
display
and
directed
evolution
systems
have
transformed
synthetic
Ab
discovery,
engineering,
optimization,
vastly
expanding
number
of
clones
able
be
experimentally
screened
binding.
Moreover,
burgeoning
integration
high-throughput
screening,
deep
sequencing,
machine
learning
has
further
augmented
in
vitro
promising
accelerate
design
process
massively
expand
sequence
space
interrogated.
In
this
Brief
Review,
we
discuss
experimental
computational
tools
employed
engineering
optimization.
We
explore
challenges
posed
by
developing
infectious
diseases,
prospects
leveraging
learning–guided
protein
prospectively
resistant
viral
escape.
Proceedings of the National Academy of Sciences,
Journal Year:
2024,
Volume and Issue:
121(15)
Published: April 1, 2024
Antigenic
drift
of
SARS-CoV-2
is
typically
defined
by
mutations
in
the
N-terminal
domain
and
receptor
binding
spike
protein.
In
contrast,
whether
antigenic
occurs
S2
remains
largely
elusive.
Here,
we
perform
a
deep
mutational
scanning
experiment
to
identify
that
affect
three
apex
public
antibodies.
Our
results
indicate
spatially
diverse
mutations,
including
D950N
Q954H,
which
are
observed
Delta
Omicron
variants,
respectively,
weaken
these
Although
antibodies
known
be
nonneutralizing,
show
they
confer
protection
vivo
through
Fc-mediated
effector
functions.
Overall,
this
study
indicates
can
undergo
drift,
represents
potential
challenge
for
development
more
universal
coronavirus
vaccines.
Frontiers in Immunology,
Journal Year:
2025,
Volume and Issue:
15
Published: Jan. 3, 2025
The
unrelenting
emergence
of
SARS-CoV-2
variants
has
significantly
challenged
the
efficacy
existing
COVID-19
vaccines.
Enhancing
stability
and
immunogenicity
spike
protein
is
critical
for
improving
vaccine
performance
addressing
variant-driven
immune
evasion.
We
developed
an
mRNA-based
vaccine,
RV-1730,
encoding
Delta
variant
with
S6P
mutation
to
enhance
immunogenicity.
vaccine's
protective
were
evaluated
in
preclinical
models,
including
monovalent
(RV-1730)
bivalent
(RV-1731)
formulations
targeting
BA.1
variants.
Additionally,
effectiveness
RV-1730
as
a
heterologous
booster
following
primary
vaccination
BNT162b2
(Pfizer-BioNTech)
mRNA-1273
(Moderna-NIAID)
was
assessed.
elicited
stronger
B
T
cell
responses
more
durable
neutralizing
antibodies
compared
S2P-based
RV-1731
demonstrated
broad
activity
against
emerging
variants,
XBB1.5
JN.1.
Importantly,
when
used
initial
immunization
or
mRNA-1273,
enhanced
antibody
titers
multiple
Omicron.
Both
provided
superior
protection
indicating
due
mutation.
incorporation
into
enhances
strong
broad-spectrum
underscore
their
potential
versatile
effective
strategies
its
evolving
Nature Communications,
Journal Year:
2024,
Volume and Issue:
15(1)
Published: June 28, 2024
Abstract
Evolution
of
SARS-CoV-2
alters
the
antigenicity
immunodominant
spike
(S)
receptor-binding
domain
and
N-terminal
domain,
undermining
efficacy
vaccines
antibody
therapies.
To
overcome
this
challenge,
we
set
out
to
develop
a
vaccine
focusing
responses
on
highly
conserved
but
metastable
S
2
subunit,
which
folds
as
spring-loaded
fusion
machinery.
We
describe
strategy
for
prefusion-stabilization
high
yield
recombinant
production
trimers
with
native
structure
antigenicity.
demonstrate
that
our
design
is
broadly
generalizable
sarbecoviruses,
exemplified
SARS-CoV-1
(clade
1a)
PRD-0038
3)
subunits.
Immunization
mice
prefusion-stabilized
trimer
elicits
reactive
sarbecovirus
antibodies
neutralizing
titers
comparable
magnitude
against
Wuhan-Hu-1
immune
evasive
XBB.1.5
variant.
Vaccinated
were
protected
from
weight
loss
disease
upon
challenge
XBB.1.5,
providing
proof-of-principle
machinery
vaccines.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 4, 2025
Abstract
Giant
unilamellar
vesicles
(GUVs)
embody
biomimetic
membranes
with
compartmentalization
that
serve
not
only
as
simplified
models
to
better
understand
complex
biochemical
and
biophysical
processes,
but
also
a
chassis
for
the
bottom-up
assembly
of
synthetic
cells.
Recently,
double
emulsion
droplet
microfluidics
has
proven
be
promising
platform
their
production,
offering
greater
throughput,
control,
reproducibility
over
traditional
methods.
However,
interplay
parameters—particularly
under
biocompatible
conditions—that
influence
multiphase
fluid
dynamics
dewetting
process
underlying
GUV
production
been
thoroughly
studied,
limiting
democratization
approach.
In
this
study,
we
systematically
investigate
how
lipid
composition
concentration,
aqueous
phase
conditions,
confinement,
effects
promote
or
impede
process.
We
show
prevalent
use
high
concentrations
glycerol
P188
are
unnecessary,
altered
restricted
surfactant
usage
can
tuned
by
adjusting
chip
dimensions
multi-phase
compositions.
Guided
these
findings,
achieved
robust,
throughput
monodisperse
GUVs
using
0.1%
no
salts.
Our
results
improve
reliability
accessibility
droplet-microfluidics
platforms
catalyze
advances
in
biophysics,
biology,
drug
discovery.
Vaccines,
Journal Year:
2025,
Volume and Issue:
13(3), P. 315 - 315
Published: March 14, 2025
Background/Objectives:
As
with
many
viral
fusion
proteins,
the
native
conformation
of
SARS-CoV-2
Spike
is
metastable.
Most
COVID-19
vaccines
utilize
a
stabilized
(Spike-2P)
containing
two
proline
substitutions,
and
subsequently,
further
variant
four
additional
Spike-6P,
has
been
developed.
In
an
alternative
approach,
we
introduced
aspartic
acid
residues
(2D)
in
HR1
region
at
positions
that
are
exposed
buried
pre-
postfusion
states,
respectively,
to
destabilize
conformation.
Methods:
The
recombinant
protein
constructs
were
expressed
mammalian
cell
culture
characterized
for
their
yield
antigenicity,
formulations
then
used
immunize
hamsters.
After
immunizations,
hamsters
challenged
live
B.1.351
virus
evaluation
protective
efficacy.
Results:
introduction
mutations
resulted
approximately
six-fold
increase
expression,
comparable
Spike-2P.
When
2D
combined
above
(Spike-4P-2D),
this
led
three-
four-fold
enhancement
similar
seen
Spike-6P.
formulated
oil-in-water
emulsion
adjuvant
Sepivac
SWE,
2P,
2D,
6P,
4P-2D
variants
all
protected
female
against
heterologous
challenge
elicited
high
titers
neutralizing
antibodies.
Conclusions:
We
suggest
destabilization
through
charged
amino
acids
sites
offers
general
strategy
enhance
stability
native,
prefusion
surface
proteins.